- Virginia Valentine-Coles: Co-inventor
- Anson Parker: Co-inventor.
- Anson began his studies at the University of Virginia. After taking several years to run a data management firm in DC he returned to work with Dr. Patrice Guyenet in his neuropharmacology lab. Under Dr. Kretsinger he learned protein structure prediction and soon delved into his own studies. After several years of independent research he formulated the first patented rendering of the enzymatic THC process. Anson enjoys working on alternative energy machines and street theater. His blog A la Digital covers his interests.
- Kenneth J. Wilson, PhD: Technical Advisor
- Dr. Wilson was born in Sacramento, California and has lived in California, Honolulu, Guam, Chicago, Virginia, Pennsylvania and New Jersey but prefers Costa Rica and Charlottesville. He received his PhD in Organic Chemistry from The University of Virginia in 1992 developing a synthesis of the polyketide Amphotericin B in the laboratories of Dr. Glenn McGarvey. Upon completion of his doctorate, Ken received a two-year postdoctoral appointment to The University of Chicago working with Dr. William D. Wulff on new synthetic methods using chromium carbenes to synthesize the anti-cancer natural product Fostriecin. From there he moved back to California and helped develop blood decontamination systems at Cerus Corporation, some of which have now gained approval for commercial use in Europe. After returning to the East coast in 1997, Ken was employed by 3-Dimensional Pharmaceuticals, which was subsequently purchased by Johnson & Johnson, where he served as both an investigator in medicinal chemistry and is presently a Senior Scientist in the High Output Synthesis group. He currently resides in Media, PA with his 4 1/2 year old son Jerry.